Capital Fund Management (CFM)
GSK icon

Capital Fund Management (CFM)’s GSK GSK Stock Holding History

Capital Fund Management (CFM)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Sell
43,300
-188,400
-81% -$10.2M 0.01% 1272
2025
Q4 		$11.4M Buy
231,700
+89,500
+63% +$4.17M 0.03% 756
2025
Q3 		$6.14M Buy
142,200
+32,500
+30% +$1.27M 0.02% 1121
2025
Q2 		$4.21M Sell
109,700
-64,500
-37% -$2.46M 0.01% 1259
2025
Q1 		$6.75M Sell
174,200
-80,400
-32% -$2.94M 0.02% 869
2024
Q4 		$8.61M Buy
254,600
+169,200
+198% +$6.09M 0.02% 813
2024
Q3 		$3.49M Buy
85,400
+62,100
+267% +$2.54M 0.01% 1187
2024
Q2 		$897K Buy
+23,300
New +$980K ﹤0.01% 1640
2023
Q2 		– Sell
-24,400
Closed -$868K – 1758
2023
Q1 		$868K Sell
24,400
-82,000
-77% -$2.87M ﹤0.01% 1312
2022
Q4 		$3.74M Buy
106,400
+51,100
+92% +$1.7M 0.03% 728
2022
Q3 		$1.63M Buy
+55,300
New +$2.1M 0.01% 920
2022
Q1 		– Sell
-8,160
Closed -$450K – 1579
2021
Q4 		$450K Buy
+8,160
New +$424K ﹤0.01% 1456
2018
Q3 		– Sell
-6,080
Closed -$306K – 2074
2018
Q2 		$306K Buy
+6,080
New +$306K ﹤0.01% 1780
2018
Q1 		– Sell
-10,160
Closed -$450K – 1965
2017
Q4 		$450K Buy
+10,160
New +$469K ﹤0.01% 1495
2015
Q2 		– Sell
-6,880
Closed -$397K – 1554
2015
Q1 		$397K Sell
6,880
-21,440
-76% -$1.23M 0.01% 1127
2014
Q4 		$1.51M Buy
28,320
+3,680
+15% +$206K 0.02% 771
2014
Q3 		$1.42M Buy
24,640
+16,640
+208% +$1.02M 0.02% 805
2014
Q2 		$535K Sell
8,000
-7,120
-47% -$482K 0.01% 1193
2014
Q1 		$1.01M Sell
15,120
-33,520
-69% -$2.27M 0.01% 958
2013
Q4 		$3.25M Sell
48,640
-320
-0.7% -$20.7K 0.04% 535
2013
Q3 		$3.07M Buy
+48,960
New +$3.15M 0.04% 500

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital Fund Management (CFM)'s GSK Position: Q1 2025 in Review

Capital Fund Management (CFM) sold out of GSK (GSK) in Q1 2025, closing a stake of 285,867 shares — an estimated $10.5M sold.

Capital Fund Management (CFM) first reported a position in GSK in Q1 2014 and held it in 23 quarters. The position peaked at $23.3M in Q4 2022. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Capital Fund Management (CFM) reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 285,867 GSK shares in Q1 2025, an estimated $10.5M.
  • Capital Fund Management (CFM) first reported a position in GSK in Q1 2014 and held it in 23 quarters.
  • Capital Fund Management (CFM)'s GSK position peaked at $23.3M in Q4 2022.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2025, filed 14 May 2025.